E
ZyVersa Therapeutics, Inc. ZVSA
$0.7899 -$0.0111-1.39%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

09/30/2024 06/30/2024 03/31/2024 12/31/2023 09/30/2023
Net Income 13.11% 2.23% 78.81% -359.57% 96.30%
Total Depreciation and Amortization -83.65% 300.00% 102.29% -195.62% 4,465.38%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items -1.11% -47.68% -97.43% 7,980.78% -99.80%
Change in Net Operating Assets 135.63% 153.57% 9.78% -182.45% -43.55%
Cash from Operations 66.33% 49.32% -35.49% -197.67% -129.74%
Capital Expenditure -- -- -- -- --
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -- -- -- -- --
Cash from Investing -- -- -- -- --
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock -- -100.00% -46.55% 63.05% -72.16%
Repurchase of Common Stock -- -- -- -- 100.00%
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- 100.00% 97.80%
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -18.84% 53.58%
Cash from Financing -- -100.00% -38.51% 90.09% 456.25%
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 100.18% -73.36% -170.82% 15.48% 228.64%
Weiss Ratings